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Background: Previous studies have shown that migraine and sleep disturbances are closely associated. Excessive
daytime sleepiness (EDS) is a common symptom of various types of sleep disturbance. Findings from clinic-based
studies suggest that a high percentage of migraineurs experience EDS. However, the prevalence and clinical impact
of EDS among migraineurs at the population level have rarely been reported. The objective of this study was to
investigate the prevalence and impact of EDS among migraineurs using a population-based sample in Korea.
Methods: We selected a stratified random sample of Koreans aged 19 to 69 years and evaluated them using a
semi-structured interview designed to identify EDS, headache type, and the clinical characteristics of migraine. If the
score on the Epworth Sleepiness Scale (ESS) was more than or equal to 11, the participant was classified as having EDS.
Results: Of the 2,695 participants that completed the interview, 143 (5.3 %) and 313 (11.6 %) were classified as having
migraine and EDS, respectively. The prevalence of EDS was significantly higher in participants with migraine (19.6 %)
and non-migraine headache (13.4 %) compared to non-headache controls (9.4 %). Migraineurs with EDS had higher
scores on the Visual Analogue Scale (VAS) for headache intensity (6.9 ± 1.8 vs. 6.0 ± 1.9, p = 0.014) and Headache Impact
Test-6 (59.8 ± 10.2 vs. 52.5 ± 8.2, p < 0.001) compared to migraineurs without EDS.
Conclusions: Approximately 20 % of migraineurs had EDS in this population-based sample. Excessive daytime
sleepiness was associated with an exacerbation of some migraine symptoms.
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Migraine and sleep disturbances are common neuro-
logical problems in the general population [1–3]. The
close association between the two conditions has been
reported in numerous clinic- and population-based stud-
ies. Both excessive sleep and sleep deprivation are com-
mon triggering factors of migraine and sleep may
terminate an attack of migraine [4, 5]. Insomnia is a
common comorbidity of migraine in cross-sectional and
longitudinal studies [6, 7]. Habitual snoring and sleep
bruxism are associated with an exacerbation of migraine
[8, 9]. Morning headache in obstructive sleep apnea
(OSA) patients may exhibit migraine-like headache [10].* Correspondence: chumk@hallym.ac.kr
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the Creative Commons license, and indicate ifRestless legs syndrome has been reported to be associ-
ated with migraine in case-controlled and population-
based studies [11, 12].
Excessive daytime sleepiness (EDS) is defined as
‘sleepiness in a situation when an individual would be
expected to be awake and alert’ [13]. EDS is not a dis-
order in and of itself, but represents symptoms of several
broad conditions including poor sleep quality, depres-
sion, anxiety, sleep-disordered breathing, and obesity
metabolic syndrome [14]. Besides impairing quality of
life, EDS may lead to potentially problematic conditions
such as attention deficits and sleep attacks [15]. The
prevalence of EDS has ranged between 10 % and 20 % in
the general population [16, 17].
For psychiatric conditions, anxiety and depression has
been reported to be associated with EDS. Individuals
with depression have frequently EDS (57.1 %) and ais distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
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depression in survey using Beck Depression Inventory
[18, 19]. Anxiety was associated with an increased occur-
rence of EDS in a 20-year prospective community-based
study from Switzerland [17].
The association between EDS and several common
neurological diseases such as Parkinson’s disease, epi-
lepsy, and migraine has been previously reported. A
case-controlled study from Italy noted that subjects with
episodic migraine (EM) showed an increased odds ratio
[14 % vs. 5 %; odds ratio (OR) = 3.1; 95 % confidence
interval (CI) 1.1–8.9] for EDS compared to age- and sex-
matched healthy controls [15]. Another case-controlled
study showed a positive association between EDS and
chronic migraine (CM) [20]. A case-series study in the
United States showed that a significant proportion of
participants with migraine also had EDS [21]. A
community-based study in Norway showed increased
ORs (OR = 3.3, 95 % CI 1.0–10.2) for EDS among
migraineurs compared to headache-free individuals [22].
However, previous reports regarding the association
between EDS and migraine were predominantly clinic-
based studies and the association between them has
seldom been examined in the general population. In
addition, the clinical characteristics of migraine associ-
ated with EDS have not yet been reported.
The Korean Headache-Sleep Study (KHSS) is a nation-
wide population-based interview survey regarding head-
ache and sleep disturbance [12]. It provides an opportunity
to assess comorbidity between EDS and migraine as well
as elucidate the clinical characteristics of migraine relative
to the presence of comorbid EDS. The present study in-
vestigated 1) the prevalence of migraine and/or EDS
in a general population-based sample; 2) the comor-
bidity between migraine and EDS in association with
potential covariates such as anxiety, depression and
poor sleep quality; and 3) the clinical characteristics
of migraine comorbid with EDS using the data avail-
able from the KHSS.
Methods
Study population and survey process
The study was a nationwide, cross-sectional survey of
headache and sleep in the Korean population in adults
aged 19–69 years. The study design and methods have
been previously described in detail [12]. Briefly, we
adopted a two-stage systematic random sampling method
in all Korean territories except Jeju-do, proportional to the
distribution of the population, which resulted in a sample
of 2,695 individuals. Subjects were stratified according to
age, gender, size of residential area and educational level.
To minimize bias, we informed participants that the topic
of the survey was social health issues rather than
headache. Trained interviewers conducted structuredinterviews using a questionnaire to diagnose headache
type, sleep duration, sleepiness, anxiety, and depression
door-to-door using a face-to-face interview. The interview
included questions on headache symptoms and sleep sta-
tus. All interviewers were employed by Gallup Korea and
had previous social survey interviewing experience. The
study was conducted from November 2011 to January
2012. It was approved by the institutional review board/
ethics committee of Hallym University Sacred Heart Hos-
pital and was performed in accordance with the ethical
standards described in the 1964 Declaration of Helsinki
and its subsequent amendments [23]. Written informed
consent was obtained from all participants.
Migraine assessment
We diagnosed migraine using a questionnaire. The ques-
tionnaire established a headache profile which was de-
signed to align with the second edition of the
International Classification of Headache Disorders
(ICHD-2) [24]. We investigated the severity of headache
based on its effects on daily activity (mild, moderate, or
severe) and using a visual analogue scale (VAS). Further-
more, we surveyed the headache frequency as following
question. “How many days do you experience the head-
ache every month?” Migraine was diagnosed based on
the ICHD-2 criteria for migraine without aura (code 1.1)
[24]. We did not attempt to separately diagnose mi-
graine with and without aura. As such, both were in-
cluded in the present study. The questions used to
diagnose migraine have 75.0 % sensitivity and 88.2 %
specificity, verified by comparing the diagnoses from the
survey with those of doctors obtained from an additional
telephone interview. This validation process has been
previously described in detail [25].
Non-migraine headache assessment
If a participant responded positively to the question ‘In
the past year, have you had at least 1 headache lasting
more than 1 min?’ and was not diagnosed as having mi-
graine, she or he was diagnosed as having non-migraine
headaches.
Excessive daytime sleepiness, sleep duration and poor
sleep quality assessment
We used the Epworth Sleepiness Scale (ESS) for
assessing participants’ daytime sleepiness. The total
ESS score ranged from 0 to 24. If a participant scored
more than or equal to 11 on the ESS, they were clas-
sified as having EDS. The ESS has been previously
validated in the Korean language [26]. The Korean
version of the ESS has been reported to have good
internal consistency (Cronbach’s α = 0.90) and test-
retest reliability (r = 0.78 to 0.93)
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of participants. Average sleep duration was defined as
[(weekday sleep duration × 5) + (weekend sleep dur-
ation × 2)]/7. Short sleep duration was defined as average
sleep duration of less than 6 h and poor sleep quality
was defined as a Pittsburgh Sleep Quality Index score
(PSQI) of more than 5.
Anxiety and depression assessment
We used the Goldberg Anxiety Scale (GAS) for measur-
ing self-reported anxiety symptomology. If a participant
provides a positive response for two or more of the first
four screening questions and five or more of all GAS
questions, they were characterized as having anxiety
[27]. The Korean version of the GAS has been reported
to have 82.0 % sensitivity and 94.4 % specificity [28].
The Patient Health Questionnaire-9 (PHQ-9) was used
for diagnosing depression [29]. If a participant’s PHQ-9
score was 10 or more, they were categorized as having
depression. The Korean PHQ-9 has been found to have
81.1 % sensitivity and 89.9 % specificity [30].
Statistical analysis
We compared EDS prevalence among non-headache
controls, and participants with non-migraine headache
and migraine, using the chi-square test. We conducted a
multivariable logistic regression analysis, adjusting for
anxiety, depression, short sleep duration (average sleep
duration less than 6 h), and poor sleep quality (a PSQI
score of more than 5). We used logistic regression to
evaluate the association between migraine and EDSFig. 1 Flow chart depicting participation in the Korean Headache-Sleep Stuaccording to headache frequency and calculated odds ra-
tios (ORs) and their 95 % confidence intervals (CIs). We
compared the clinical characteristics of participants with
migraine with and without EDS using Student’s t-test for
continuous variables and the chi-square test for categor-
ical variables. p-values of <0.05 were considered statisti-
cally significant. The results were analysed using the
statistical software SPSS 22.0 (IBM, Armonk, NY, USA).
As with most survey studies, missing data from a lack
of responding occurred on several items. The data re-
ported are the available data and therefore some vari-
ables deviate from the overall sample size of n = 2,695.
Imputation techniques were not employed to minimize
non-response effects [31].Results
Survey
Our interviewers approached 7,430 individuals and
3,114 of them agreed to take the survey. Of them, 2,695
subjects completed the survey (Fig. 1). The distribution
of age, gender, size of residential area, and educational
level were not significantly different from those of the
Korean general population (Table 1).Prevalence of migraine and non-migraine headache
Of the 2,695 respondents, 143 (5.3 %) met the ICHD-2
criteria for migraine and 1,130 (41.9 %) were classified
as having non-migraine headache. Finally, 1,422 partici-
pants (52.8 %) were classified as non-headache controls.dy
Table 1 Sociodemographic distribution of all survey participants including migraine, non-migraine headache, and excessive daytime
sleepiness
Sample number Total population p-value Migraine Non-migraine headache Excessive daytime
sleepiness
N (%) N (%) N, % (95 % CI) N, % (95 % CI) N, % (95 % CI)
Gender
Men 1345 (49.3a) 17,584,365 (50.6) 0.854b 36, 2.7 (1.8–3.5) 471, 35.0 (32.4–37.6) 161, 12.0 (10.2–13.7)
Women 1350 (50.7 a) 17,198,350 (49.4) 107, 7.9 (6.5–9.4) 659, 49.0 (46.2–51.5) 152, 11.3 (9.6–12.9)
Age
19–29 542 (20.5 a) 7,717,947 (22.2) 0.917b 25, 4.5 (2.7–6.2) 231, 42.6 (38.4–46.8) 52, 9.6 (7.1–12.1)
30–39 604 (21.9 a) 8,349,487 (24.0) 42, 7.0 (4.9–9.1) 269, 44.5 (40.6–48.5) 71, 11.8 (9.2–14.3)
40–49 611 (23.1 a) 8,613,110 (24.8) 39, 6.5 (4.5–8.4) 277, 45.3 (41.4–49.3) 62, 10.1 (7.7–12.5)
50–59 529 (18.9 a) 6,167,505 (17.7) 22, 4.1 (2.4-5.9) 204, 38.6 (34.4-42.7) 66, 12.5 (9.7-15.3)
60–69 409 (15.6 a) 3,934,666 (11.3) 15, 3.9 (2.0–5.7) 149, 36.4 (31.7–41.1) 62, 15.2 (11.7–18.6)
Size of residential area
Large city 1248 (46.3 a) 16,776,771 (48.2) 0.921b 76, 6.1 (4.8–7.5) 525, 42.1 (39.3–44.8) 150, 12.0 (10.2–13.8)
Medium-to-small city 1186 (44.0 a) 15,164,345 (43.6) 48, 4.0 (2.9–5.2) 488, 41.1 (38.3–43.9) 134, 11.3 (9.5–13.1)
Rural area 261 (9.7 a) 2,841,599 (8.2) 19, 7.4 (4.2–10.6) 117, 44.8 (38.8–50.9) 29, 11.1 (7.3–14.9)
Educational level
Middle school or less 393 (14.9 a) 6,608,716 (19.0) 0.752b 22, 5.5 (4.2–7.7) 165, 42.0 (37.1–46.9) 58, 14.8 (11.2–18.3)
High school 1208 (44.5 a) 15,234,829 (43.8) 50, 5.0 (3.8–6.3) 502, 41.6 (38.8–44.3) 135, 11.2 (9.4–13.0)
College or more 1068 (39.6 a) 12,939,170 (37.2) 60, 5.6 (4.3–7.0) 457, 42.7 (39.8–45.8) 119, 11.1 (9.3–13.0)
Not responded 1, 3.8 (0.0–11.8) 6, 5.3 (0.3–9.6) 1, 3.8 (0.0–11.8)
Total 2695 (100.0 a) 34,782,715 (100.0) 143, 5.3 (4.5–6.2) 1130, 41.9 (40.0–43.8) 313, 11.6 (10.4–12.8)
CI Confidence Interval
aAdjusted after age, gender, size of residential area and educational level
bCompared gender, age group, size of residential area, and educational level distributions between the sample of the present study and total population of Korea
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Three hundred and thirteen (11.6 %) subjects reported
ESS scores in an excess of 11 and were therefore classi-
fied as having EDS (Table 1). Among the 143 partici-
pants with migraine, 28 (19.6 %) were classified as also
having EDS. Of the 1,130 participants with non-migraine
headache and the 1,422 classified as non-headache con-
trols, 151 (13.4 %) and 134 (9.4 %) were classified as hav-
ing EDS, respectively. The prevalence of EDS was
significantly higher among participants with migraine
(OR = 2.3, 95 % CI = 1.5–3.7, p < 0.000) and non-migraine
headache (OR = 1.5, 95 % CI = 1.2–1.9, p = 0.002) com-
pared to non-headache controls. However, the prevalence
of EDS was not significantly different between participants
with migraine and those with non-migraine headache
(OR = 1.6, 95 % CI = 1.0–2.5, p = 0.055) (Fig. 2).
Univariable logistic regression revealed that EDS
prevalence among participants with migraine (OR = 2.3,
95 % CI = 1.5–3.7, p < 0.001) and non-migraine headache
(OR = 1.5, 95 % CI = 1.2–1.9, p = 0.002) had increased
ORs for EDS compared to non-headache controls. Anx-
iety (OR = 2.4, 95 % CI = 1.7–3.2, p < 0.001), depression
(OR = 6.2, 95 % CI = 4.2–9.1, p < 0.001), short sleepduration (OR = 1.4, 95 % CI = 0.9–1.9, p = 0.122), and
poor sleep quality (OR = 3.3, 95 % CI = 2.6–4.3) also had
increased ORs for EDS. In the multivariable logistic re-
gression for EDS adjusting for anxiety and depression
(Model 1), migraine was not associated with increased
ORs for EDS. After adjusting for short sleep duration
(<6 h) and poor sleep quality (PSQI score > 5) (Model 2),
however, non-migraine headache and migraine were re-
vealed to have statistically significant ORs for EDS. The
final model adjusting for anxiety, depression, short sleep
duration, and poor sleep quality (Model 3), indicated
that those with non-migraine headache and migraine did
not have statistically significant ORs for EDS relative to
non-headache controls (Table 2).
Excessive daytime sleepiness according to the headache
frequency of migraine
Although not statistically significant, there was a tendency
towards increased prevalence of EDS in migraineurs with
at least 10 attacks per month (OR = 1.5, 95 % CI =
0.4–5.8, p = 0.557) compared to those with less than
one attack a month. The ESS scores were not signifi-
cantly different among migraineurs with less than
Fig. 2 Comparison of the prevalence of EDS among participants *p < 0.05
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month (7.4 ± 4.6), or at least 10 attacks per month
(7.2 ± 4.9, p = 0.330).Clinical characteristics of subjects having migraine with
and without EDS
We investigated the headache characteristics, head-
ache frequency, VAS score for pain intensity, HIT-6
scores, psychiatric comorbidities such as anxiety and
depression of participants with migraine grouped
according the presence of EDS. Unilateral pain
(39.3 % vs. 60.9 %, p = 0.039) was less prevalent and
moderate-to-severe pain intensity (96.4 % vs. 76.5 %,
p = 0.017) was more prevalent among migraineurs
with EDS compared to migraineurs without EDS.
Additionally, VAS scores for pain intensity (6.9 ± 1.8
vs. 6.0 ± 1.9, p = 0.014), HIT-6 scores (59.8 ± 10.2 vs.
52.5 ± 8.2, p < 0.001) and the prevalence of depres-
sion (42.9 % vs. 10.4 %, p < 0.001) was higher in
migraineurs with EDS than those without EDS. The
other measures did not significantly differ with the




adjusted for anxiety and
depression (Model 1)
OR P-value OR P-value
Non-migraine headache 1.5 (1.2–1.9) 0.002 1.3 (1.0–1.7) 0.042
Migraine 2.3 (1.5–3.7) <0.001 1.6 (1.0–2.6) 0.069
Anxiety 2.4 (1.7–3.2) <0.001 1.3 (0.9–1.9) 0.135







EDS Excessive daytime sleepiness, PSQI Pittsburgh Sleep Quality IndexDiscussion
The key findings in the present study were: (1) the
prevalence of migraine and EDS in the Korean general
population were 5.3 % and 11.6 %, respectively; (2) the
prevalence of EDS was significantly higher among partic-
ipants with migraine (19.6 %) and non-migraine head-
ache (13.4 %) compared to non-headache controls
(9.4 %); and (3) some clinical characteristics of migraine
were more profound among migraineurs with EDS com-
pared to migraineurs without EDS.
The 1-year prevalence of migraine in the present study
was 5.3 % (2.7 % for men and 7.9 % for women). The 1-
year prevalence of migraine in Asian countries has been
found to range between 4.7 % and 9.1 % in most previ-
ous studies [32]. Our findings are similar to those re-
ported in previous studies from Asian countries. The
prevalence of migraine in Asia is relatively lower than
that of western countries.
We found that the prevalence of EDS was 11.6 % in
the Korean general population. Previous population-
based studies have reported EDS using ESS mostly ran-
ging from 10 % to 20 %. Three Australian studies among
adults reported that EDS prevalence ranged from 11.7 %s by headache condition
Multivariable analysis, adjusted
for sleep duration and PSQI
Score (Model 2)
Multivariable analysis, adjusted for
anxiety, depression, sleep duration
and PSQI score (Model 3)
OR P-value OR P-value
1.3 (1.0–1.7) 0.037 1.2 (0.9–1.5) 0.175
1.8 (1.2–2.9) 0.010 1.4 (0.8–2.2) 0.206
1.2 (0.8–1.7) 0.504
3.7 (2.4–5.8) <0.001
0.8 (0.5–1.2) 0.790 0.8 (0.5–1.1) 0.143
3.3 (2.5–4.3) <0.001 3.0 (2.2–3.8) <0.001
Table 3 Clinical characteristics and impact of migraine according to excessive daytime sleepiness
Migraine with EDS, N = 28 Migraine without EDS, N = 115 P-value
Headache characteristics
Unilateral pain, N (%) 11 (39.3) 70 (60.9) 0.039
Pulsating quality, N (%) 18 (64.3) 90 (78.3) 0.123
Moderate-to-severe
pain intensity, N (%)
27 (96.4) 88 (76.5) 0.017
Aggravation by
movement, N (%)
23 (82.1) 77 (67.0) 0.116
Nausea, N (%) 23 (82.1) 102 (88.7) 0.349
Vomiting, N (%) 11 (39.3) 44 (38.3) 0.920
Photophobia, N (%) 16 (57.1) 68 (59.1) 0.848
Phonophobia, N (%) 23 (82.1) 78 (67.8) 0.136
Osmophobia, N (%) 14 (50.0) 54 (47.0) 0.722
Headache frequency, mean ± SD 5.1 ± 7.2 3.5 ± 5.9 0.178
VAS for pain intensity, mean ± SD 6.9 ± 1.8 6.0 ± 1.9 0.014
HIT-6 score,
mean ± SD
59.8 ± 10.2 52.5 ± 8.2 <0.001
Anxiety, N (%) 11 (39.3) 32 (27.8) 0.236
Depression, N (%) 12 (42.9) 12 (10.4) <0.001
EDS Excessive daytime sleepiness, VAS Visual Analogue Scale, HIT-6 Headache Impact Test-6
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EDS prevalence of 9.0 % [36]. A previous study using
data from the Korean Genome Epidemiology Study
found that the prevalence of EDS was 12.2 % [37]. Our
study showed a similar EDS prevalence to that from pre-
vious studies and therefore verified the reliability of the
sampling and EDS diagnosis in our study.
Excessive daytime sleepiness has been reported to be
associated with poor sleep quality and psychiatric condi-
tions [38, 39]. Poor sleep quality is reported to be associ-
ated psychiatric conditions [40–42]. Furthermore,
migraineurs were reported to have poor sleep quality
and higher psychiatric comorbid conditions compared to
non-headache controls [43–45]. In the present study,
participants with migraine had an increased OR for EDS
compared to non-headache controls in the univariable
regression analysis. After adjusting for anxiety, depres-
sion, short sleep duration, and poor sleep quality, mi-
graine was no longer a significant predictor of EDS
while poor sleep quality and depression maintained sig-
nificant associations with EDS (Table 3). Previous case-
controlled studies have demonstrated similar findings.
EM and CM had increased ORs for EDS in a univariate
analysis [15, 20]. However, after adjusting for poor sleep
quality, drugs, and gender, EM and CM were no longer
statistically significant. These findings suggest that a sig-
nificant association between migraine and EDS in a uni-
variable analysis may be attributable to poor sleep
quality and/or depression among migraineurs rather
than the migraine itself.In the present study, migraineurs with EDS experi-
enced more severe headache intensity, reported a higher
impact of the headache, and more depressive sympto-
mology than those without EDS. These findings suggest
that migraineurs with EDS have more severe clinical
burden than migraineurs without EDS. Considering find-
ings in the present study, physicians should carefully in-
vestigate the level of EDS and factors that exacerbate it,
such as poor sleep quality and depressive symptomology
when caring for patients with migraine.
This study had some limitations. First, although our
research is a large population-based study with low sam-
pling error, its statistical power for executing a subgroup
analysis was limited. Some results might not have
reached statistical significance because of the limited
sample size. Second, this study is cross-sectional and the
directionality of the association is uncertain. It cannot
be determined whether migraine causes EDS or vice
versa. Third, we surveyed the sleep habits of partici-
pants based solely on self-report. Further, we did not
use any tool to evaluate characteristics of sleep such
as polysomnography, which could further explore the
sleep architecture, total sleep time, sleep efficiency, or
other relevant sleep variables among participants with
EDS.
Our study has several strengths. First, this study has a
large sample size in a population-based setting and the
estimated sampling error was low. Second, we investi-
gated risk factors for EDS after adjusting for sleep dur-
ation. Third, we assessed the clinical features of
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without EDS.
Conclusions
In summary, migraineurs had a higher prevalence of
EDS relative to non-headache controls. Further, migrai-
neurs with EDS experienced a more severe headache,
depressive mood, and higher impact of headache. The
presence of EDS should be carefully evaluated in migrai-
neurs, in order to relieve the headache as well as reduce
the impact of headache.
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